FIRST SUPPLEMENTAL INDENTUREFirst Supplemental Indenture • May 7th, 2018 • Amneal Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 7th, 2018 Company Industry JurisdictionFIRST SUPPLEMENTAL INDENTURE, dated as of November 6, 2017 (this “First Supplemental Indenture”), to the Indenture dated as of June 30, 2015 (the “Indenture”) between Impax Laboratories, Inc. (the “Company”), a Delaware corporation, and Wilmington Trust, National Association, a national banking association, as Trustee (the “Trustee”). Each term used herein which is defined in the Indenture has the meaning assigned to such term in the Indenture unless otherwise specifically defined herein, in which case the definition set forth herein shall govern.
FIRST SUPPLEMENTAL INDENTUREFirst Supplemental Indenture • November 7th, 2017 • Impax Laboratories Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 7th, 2017 Company Industry JurisdictionFIRST SUPPLEMENTAL INDENTURE, dated as of November 6, 2017 (this “First Supplemental Indenture”), to the Indenture dated as of June 30, 2015 (the “Indenture”) between Impax Laboratories, Inc. (the “Company”), a Delaware corporation, and Wilmington Trust, National Association, a national banking association, as Trustee (the “Trustee”). Each term used herein which is defined in the Indenture has the meaning assigned to such term in the Indenture unless otherwise specifically defined herein, in which case the definition set forth herein shall govern.